Skip to main content
. 2020 Jun;6(2):18–22. doi: 10.18502/CMM.6.2.2696

Table 1.

Antifungal susceptibility of otomycosis agents (Aspergillus species complex)

Species Antifungals Minimum Inhibitory Concentration (µg/mL)
Resistant (%) %ECVa
MIC MIC50 MIC90 MICGM
Aspergillus niger complex (36) Terbinafine 0.0312-0.5 0.0625 0.5 0.10509 - ND
Caspofunginb 0.0312-8 0.0312 4 0.12444 15 (41.7%) 58.3%
Fluconazole 1-128 64 128 50.79683 10 (27.8%) ND
Itraconazole 0.0312-2 0.5 1 0.39641 0 (0.0%) 100%
Miconazole 0.25-4 0.25 2 0.39685 - ND
Bifonazole 0.0312-2 0.5 1 0.29671 - ND
Econazole 0.0625-0.5 0.0625 0.125 0.07577 - ND
A. flavus complex (30) Terbinafine 0.0625-1 0.25 0.5 0.17678 - ND
Caspofunginb 0.0312-8 8 8 3.24849 23 (76.7%) 23.3%
Fluconazole 1-128 64 128 64 14 (46.7%) ND
Itraconazole 0.0312-8 0.25 1 0.30777 1 (3.3%) 96.7%
Miconazole 0.25-8 1 4 1.02337 - ND
Bifonazole 0.0312-8 2 8 1.58732 - ND
Econazole 0.0312-0.25 0.125 0.25 0.10389 - ND
A. terreus complex (1) Terbinafine 0.25 - - - - ND
Caspofunginb 8 - - - 1 (100%) 0.0%
Fluconazole 16 - - - 0 (0.0%) ND
Itraconazole 0.25 - - - 0 (0.0%) 100%
Miconazole 1 - - - - ND
Bifonazole 0.5 - - - - ND
Econazole 0.125 - - - - ND
A. nidulans complex (1) Terbinafine 1 - - - - ND
Caspofunginb 0.125 - - - 0 (0.0%) 100%
Fluconazole 128 - - - 1 (100%) ND
Itraconazole 0.125 - - - 0 (0.0%) 100%
Miconazole 1 - - - - ND
Bifonazole 2 - - - - ND
Econazole 0.125 - - - - ND

ECV: epidemiologic cutoff values, ND: not determined

a %MICs less than or equal to the ECVs (ECV=1-2 µg/ml for itraconazole, 0.06-0.12 µg/ml for caspofungin)

b Minimum effective concentration (MEC), MEC50, MEC90, and MECGM were calculated for organisms.